/Aerosolized Formulations Of Hiv Protease Inhibitors For The Treatment Of Airway Reflux
Abstract

The present invention provides methods of treating airway reflux using an HIV protease inhibitor that is capable of binding to and inhibiting the enzymatic activity of pepsin. Compositions comprising aerosolized formulations of HIV protease inhibitors are also provided.

Full Text

What is claimed is:

The present invention provides methods of treating airway reflux using an HIV protease inhibitor that is capable of binding to and inhibiting the enzymatic activity of pepsin. Compositions comprising aerosolized formulations of HIV protease inhibitors are also provided.
Timeline
Filed
05/07/2026
Published
08/27/2026
Granted
Not Available
IPC Codes(3)
A61K 31/665:having oxygen as a ring hetero atom, e.g. fosfomycin
A61K 9/00:Medicinal preparations characterised by special physical form
A61P 1/04:for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants